Latest news
Loading news…
OncXerna Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Waltham, Massachusetts, United States Founded 2018 11-50 employees For Profit
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
19
Patents
6
15 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 17
- Patents granted
- 6
- Trademarks
- 15
- IT spend
- $9M
Company Info
- Founded
- 2018
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 14
- HQ
- Waltham, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Diversity spotlight
- Women Founded; Women Led
- Closed
- Jan 1, 2023
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.2
- Trend (90d)
- 1.2
Key People at OncXerna Therapeutics
Chief Financial Officer
Chief Business Officer
19
professional contacts at OncXerna Therapeutics
Contact execs at OncXerna Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to OncXerna Therapeutics
Loading news…
FAQs about OncXerna Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.